The MetLife Inc (MET) share price is expected to increase by 9.25% over the next year. This is based on calculating the average 12-month share price estimate provided by 16 stock analysts who have covered MET. Price targets range from $81 at the low end to $98 at the high end. The current analyst consensus for MET is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
MetLife Inc has a total of 16 Wall St Analyst ratings. There are 9 buy ratings, 6 ratings, and 1 sell ratings. Since most analysts have a buy consensus rating, the expectation is that MetLife Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of MET.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Elyse Greenspan Wells Fargo | Overweight | $93 | Maintains | Nov 5, 2024 |
Alex Scott Barclays | Overweight | $90 | Maintains | Oct 31, 2024 |
Elyse Greenspan Wells Fargo | Overweight | $92 | Maintains | Oct 10, 2024 |
Daniel Bergman TD Cowen | Buy | $97 | Initiates | Oct 9, 2024 |
John Barnidge Piper Sandler | Overweight | $92 | Maintains | Oct 2, 2024 |
Suneet Kamath Jefferies | Buy | $95 | Maintains | Sep 27, 2024 |
Alex Scott Barclays | Overweight | $91 | Initiates | Sep 4, 2024 |
Nigel Dally Morgan Stanley | Overweight | $85 | Maintains | Aug 19, 2024 |
Elyse Greenspan Wells Fargo | Overweight | $86 | Maintains | Aug 12, 2024 |
Joshua Shanker B of A Securities | Buy | $96 | Maintains | Aug 1, 2024 |
Michael Ward Citigroup | Buy | $89 | Maintains | Jul 23, 2024 |
Suneet Kamath Jefferies | Buy | $86 | Maintains | Jul 18, 2024 |
Nigel Dally Morgan Stanley | Overweight | $83 | Maintains | Jul 10, 2024 |
Ryan Krueger Keefe, Bruyette & Woods | Outperform | $85 | Maintains | Jul 8, 2024 |
Jimmy Bhullar JP Morgan | Overweight | $86 | Maintains | Jul 2, 2024 |
Suneet Kamath Jefferies | Buy | $83 | Maintains | Jun 28, 2024 |
Kevin Heal Argus Research | Buy | $80 | Maintains | May 22, 2024 |
Elyse Greenspan Wells Fargo | Overweight | $85 | Maintains | May 10, 2024 |
Ryan Krueger Keefe, Bruyette & Woods | Outperform | $86 | Maintains | May 7, 2024 |
John Barnidge Piper Sandler | Overweight | $82 | Maintains | May 6, 2024 |
When did it IPO
2000
Staff Count
45,000
Country
United States
Sector/Industry
Financial Services/Insurance - Life
CEO
Mr. Michel Abbas Khalaf
Market Cap
$57.64B
In 2023, MET generated $66.41B in revenue, which was a decrease of -2.09% from the previous year. This can be seen as a signal that MET's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - MetLife reported Q3 2024 net income of $1.3 billion ($1.81/share), up from $422 million ($0.56/share) in Q3 2023. Adjusted earnings were $1.4 billion ($1.95/share). Book value rose 33% to $39.02/share.
Why It Matters - MetLife's significant net income increase and 33% rise in book value indicate strong financial health, potentially boosting investor confidence and stock value.
Summary - MetLife (MET) reported Q3 earnings of $1.93 per share, missing the Zacks estimate of $2.16 and down from $1.97 per share year-over-year.
Why It Matters - MetLife's earnings miss indicates potential operational challenges and may signal future profitability concerns, impacting stock performance and investor confidence.
Summary - MetLife, Inc. will host its Q3 2024 earnings conference call on October 31, 2024, at 9:00 AM ET, featuring key executives and analysts from major financial firms.
Why It Matters - MetLife's Q3 2024 earnings call reveals insights into financial performance, strategies, and market conditions, directly influencing stock prices and investment decisions.
Summary - MetLife, Inc. (NYSE: MET) announced a third quarter 2024 financial update from CFO John McCallion, available on their website.
Why It Matters - MetLife's CFO's financial update may signal insights into the company's performance and strategy, impacting investor sentiment and stock valuation ahead of Q3 results.
Summary - MetLife (MET) reported its quarterly performance for September 2024; investors should compare key metrics against Wall Street estimates and year-ago figures for insight.
Why It Matters - MetLife's quarterly performance compared to estimates and prior year results can indicate growth trends, profitability, and market positioning, influencing investor sentiment and stock valuation.
Summary - MET's third-quarter earnings declined due to increased expenses and a reduced recurring interest margin in its Risk and Insurance Services (RIS) segment.
Why It Matters - Higher expenses and a lower recurring interest margin in RIS could indicate reduced profitability for MET, potentially impacting share value and investor confidence.